rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2005-10-13
|
pubmed:abstractText |
BACKGROUND. The International Society for Peritoneal Dialysis (ISPD) treatment guidelines for continuous ambulatory peritoneal dialysis (CAPD) peritonitis 2000 recommended the use of cefazolin plus ceftazidime as the initial empirical therapy in patients with residual renal function (RRF). However, this treatment regimen has not been compared with the conventional regimen of cefazolin plus netilmicin in prospective, randomized controlled trials.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0085-2538
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2375-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16221243-Adult,
pubmed-meshheading:16221243-Aged,
pubmed-meshheading:16221243-Aged, 80 and over,
pubmed-meshheading:16221243-Anti-Bacterial Agents,
pubmed-meshheading:16221243-Cefazolin,
pubmed-meshheading:16221243-Ceftazidime,
pubmed-meshheading:16221243-Drug Therapy, Combination,
pubmed-meshheading:16221243-Female,
pubmed-meshheading:16221243-Humans,
pubmed-meshheading:16221243-Kidney,
pubmed-meshheading:16221243-Kidney Failure, Chronic,
pubmed-meshheading:16221243-Male,
pubmed-meshheading:16221243-Middle Aged,
pubmed-meshheading:16221243-Netilmicin,
pubmed-meshheading:16221243-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:16221243-Peritonitis,
pubmed-meshheading:16221243-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
|
pubmed:affiliation |
Division of Nephrology, University Department of Medicine, Tung Wah Hospital, Hong Kong SAR, People's Republic of China. sllui@hku.hk
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|